Epigral expands its Wind-Solar Hybrid Power plant capacity to 38.14 MW

Share

India’s leading integrated specialty chemical manufacturer, Epigral Limited, has announced an expansion of its Wind-Solar Hybrid Power plant capacity from current 18.34 MW to 38.14 MW. The company has collaborated with Prozeal Green Energy Ltd. to create a Special Purpose Vehicle (SPV) that will help in setting up an additional 19.80 MW capacity. Epigral is set to invest Rs 21.38 crore for a 26% stake in the SPV.

The strategic partnership will be formalized for a period of 25 years through an Energy Subscription Agreement (ESA) and a Share Subscription and Shareholder Agreement (SSSHA) between both the companies.

Epigral expects the capacity expansion plan to be commissioned by the fourth quarter of FY26 which will play a crucial role in fulfilling the company’s increasing power demands for its upcoming projects.

Commenting on this development, Maulik Patel, Chairman and Managing Director of Epigral Limited, said, “At Epigral, we are unwavering in our commitment to providing high-quality products to our customers while prioritizing environmental protection. The integration of a Wind-Solar Hybrid Power plant into our operations reflects our forward-thinking approach to energy while being on an aggressive growth path. The capacity expansion will be important to meet our rising energy demands. We would also like to extend our gratitude to Prozeal Green Energy Limited for being a vital part of this journey.”

Epigral has already announced plans to expand its capacity for CPVC Resin to 1,50,000 TPA (Tonnes Per Annum) and Epichlorohydrin (ECH) to 1,00,000 TPA. Moreover, the company has recently commissioned a state-of-the-art Chlorotoluene value chain plant at its Dahej facility, further enhancing its production capabilities and reinforcing its leadership in the specialty chemicals market.